Trials / Withdrawn
WithdrawnNCT05183295
Medical Food for the Dietary Management of Metastatic Colorectal Cancer
Prospective Single Arm Medical Food Study to Evaluate a Standardized Nonessential Amino Acid Restriction (NEAAR) Medical Food for the Dietary Management of Metastatic Colorectal Cancer
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Faeth Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm study evaluating the tolerability and markers of colorectal cancer with a specially designed medical food restricted in specific amino acids for the dietary management of subjects with metastatic colorectal cancer. Subjects will be receiving two FDA approved second line drug therapies, fluoropyrimidine and oxaliplatin ± bevacizumab (FOLFIRI + BEV) that are routinely prescribed in combination for metastatic colorectal cancer as part of their routine care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NEAAR Medical Food | Standardized non-essential amino acid restricted medical food |
Timeline
- Start date
- 2022-04-27
- Primary completion
- 2023-03-27
- Completion
- 2023-03-27
- First posted
- 2022-01-10
- Last updated
- 2023-04-03
Source: ClinicalTrials.gov record NCT05183295. Inclusion in this directory is not an endorsement.